The stem cell therapy market is expected to grow at a CAGR of 12.1% during the projected period. The market value is expected to increase from US$ 16.7 billion in 2024 to US$ 52.1 billion by 2034.
Attributes | Details |
---|---|
Stem Cell Therapy Market Size, 2024 | US$ 16.7 billion |
Projected Market Size, 2034 | US$ 52.1 billion |
Value-based CAGR (2024 to 2034) | 12.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Apart from analyzing the stem cell therapy market, a comprehensive evaluation has been carried out on two related markets, which are the cell culture incubator market and the cell regeneration medicine market.
Rapidly growing demand for biotechnological and pharmaceutical products has been fueling the cell culture incubator market, making it a pivotal component in the research and development of life-saving medications and innovative therapies.
The cell regeneration medicine market is witnessing a surge in demand owing to its potential to revolutionize modern medicine by offering a novel therapeutic approach for treating chronic diseases and injuries through the use of regenerative cells and tissues.
Stem Cell Therapy Market:
Attributes | Stem Cell Therapy Market |
---|---|
Value-based CAGR (2024 to 2034) | 12.1% |
Market Trends | Rising prevalence of chronic diseases, such as cancer and diabetes, has been on the rise in recent years. |
Growth Opportunities | Invest in research and development |
Cell Culture Incubator Market:
Attributes | Cell Culture Incubator Market |
---|---|
Value-based CAGR (2024 to 2034) | 6.4% |
Market Trends | Increasing regulatory approvals for cell culture-based vaccines, rising chronic disease incidence, rising demand for monoclonal antibodies, funding for cell-based research, and technological advancements in cell culture incubators |
Growth Opportunities | increased efforts of cell culture incubator companies to bring sophisticated solutions and products to the market |
Cell Regeneration Medicine Market:
Attributes | Cell Regeneration Medicine Market |
---|---|
Value-based CAGR (2024 to 2034) | 14.4% |
Market Trends | adoption of stem cell technology and the emergence and application of nanotechnology |
Growth Opportunities | widespread adoption of organ transplantation |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attributes | Details |
---|---|
Top Therapy | Autologous Cellular Immunotherapies |
CAGR (2024 to 2034) | 11.8% |
Attributes | Details |
---|---|
Top Source | Bone Marrow |
CAGR (2024 to 2034) | 11.6% |
Countries | CAGR through 2034 |
---|---|
United States | 12.3% |
United Kingdom | 13.3% |
China | 12.8% |
Japan | 13.7% |
South Korea | 14.0% |
The market is highly competitive due to the presence of several leading pharmaceutical and biotech companies. It is characterized by intense competition, rapid technological advancements, and a high degree of research and development activities aimed at developing innovative stem cell therapies. Companies are investing heavily in research and development initiatives aimed at developing novel stem cell therapies for a range of medical conditions.
Recent Development in the Stem Cell Therapy Market
In 2020, Cipla and Stempeutics formed a strategic collaboration to introduce Stempucel, a groundbreaking stem cell therapy for the treatment of critical limb ischemia. The collaboration is aimed at capitalizing on the growing demand for stem cell therapies and expanding their market share in this rapidly evolving field. The launch of Stempucel is expected to revolutionize the treatment of critical limb ischemia, a debilitating condition that affects millions of people worldwide.
The market is estimated to be valued at US$ 16.7 billion in 2024.
The market in China is expected to progress at a CAGR of 12.8% through the forecast period.
Within the therapy, the autologous cellular immunotherapies segment is expected to register an 11.8% CAGR from 2024 to 2034
The United States market is expected to rise at a 12.3% CAGR from 2024 to 2034.
The market is set to reach a valuation of US$ 52.1 billion by 2034.
The demand for stem cell therapies increased at a 15.6% CAGR from 2019 to 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Therapy 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Therapy, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapy, 2024 to 2034 5.3.1. Autologous Cellular Immunotherapies 5.3.2. Autologous Stem Cell Therapy 5.4. Y-o-Y Growth Trend Analysis By Therapy, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Therapy, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Source 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Source, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Source, 2024 to 2034 6.3.1. Bone Marrow 6.3.2. Epidermis 6.3.3. Mesenchymal Stem Cells 6.3.4. Other Sources 6.4. Y-o-Y Growth Trend Analysis By Source, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Source, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 7.3.1. Cancer 7.3.2. Cardiovascular Disorders 7.3.3. Neurodegenerative Disorders 7.3.4. Orthopedics 7.3.5. Other Applications 7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-Use 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2024 to 2034 8.3.1. Hospitals & Clinics 8.3.2. Ambulatory Surgical Centers 8.3.3. Research Centers 8.3.4. Other End-Users 8.4. Y-o-Y Growth Trend Analysis By End-Use, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By End-Use, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Therapy 10.2.3. By Source 10.2.4. By Application 10.2.5. By End-Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Therapy 10.3.3. By Source 10.3.4. By Application 10.3.5. By End-Use 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Therapy 11.2.3. By Source 11.2.4. By Application 11.2.5. By End-Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Therapy 11.3.3. By Source 11.3.4. By Application 11.3.5. By End-Use 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Therapy 12.2.3. By Source 12.2.4. By Application 12.2.5. By End-Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Therapy 12.3.3. By Source 12.3.4. By Application 12.3.5. By End-Use 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Therapy 13.2.3. By Source 13.2.4. By Application 13.2.5. By End-Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Therapy 13.3.3. By Source 13.3.4. By Application 13.3.5. By End-Use 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Therapy 14.2.3. By Source 14.2.4. By Application 14.2.5. By End-Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Therapy 14.3.3. By Source 14.3.4. By Application 14.3.5. By End-Use 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Therapy 15.2.3. By Source 15.2.4. By Application 15.2.5. By End-Use 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Therapy 15.3.3. By Source 15.3.4. By Application 15.3.5. By End-Use 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Therapy 16.2.3. By Source 16.2.4. By Application 16.2.5. By End-Use 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Therapy 16.3.3. By Source 16.3.4. By Application 16.3.5. By End-Use 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Market Share Analysis, 2023 17.1.1.1. By Therapy 17.1.1.2. By Source 17.1.1.3. By Application 17.1.1.4. By End-Use 17.2. Canada 17.2.1. Market Share Analysis, 2023 17.2.1.1. By Therapy 17.2.1.2. By Source 17.2.1.3. By Application 17.2.1.4. By End-Use 17.3. Brazil 17.3.1. Market Share Analysis, 2023 17.3.1.1. By Therapy 17.3.1.2. By Source 17.3.1.3. By Application 17.3.1.4. By End-Use 17.4. Mexico 17.4.1. Market Share Analysis, 2023 17.4.1.1. By Therapy 17.4.1.2. By Source 17.4.1.3. By Application 17.4.1.4. By End-Use 17.5. Germany 17.5.1. Market Share Analysis, 2023 17.5.1.1. By Therapy 17.5.1.2. By Source 17.5.1.3. By Application 17.5.1.4. By End-Use 17.6. UK 17.6.1. Market Share Analysis, 2023 17.6.1.1. By Therapy 17.6.1.2. By Source 17.6.1.3. By Application 17.6.1.4. By End-Use 17.7. France 17.7.1. Market Share Analysis, 2023 17.7.1.1. By Therapy 17.7.1.2. By Source 17.7.1.3. By Application 17.7.1.4. By End-Use 17.8. Spain 17.8.1. Market Share Analysis, 2023 17.8.1.1. By Therapy 17.8.1.2. By Source 17.8.1.3. By Application 17.8.1.4. By End-Use 17.9. Italy 17.9.1. Market Share Analysis, 2023 17.9.1.1. By Therapy 17.9.1.2. By Source 17.9.1.3. By Application 17.9.1.4. By End-Use 17.10. Poland 17.10.1. Market Share Analysis, 2023 17.10.1.1. By Therapy 17.10.1.2. By Source 17.10.1.3. By Application 17.10.1.4. By End-Use 17.11. Russia 17.11.1. Market Share Analysis, 2023 17.11.1.1. By Therapy 17.11.1.2. By Source 17.11.1.3. By Application 17.11.1.4. By End-Use 17.12. Czech Republic 17.12.1. Market Share Analysis, 2023 17.12.1.1. By Therapy 17.12.1.2. By Source 17.12.1.3. By Application 17.12.1.4. By End-Use 17.13. Romania 17.13.1. Market Share Analysis, 2023 17.13.1.1. By Therapy 17.13.1.2. By Source 17.13.1.3. By Application 17.13.1.4. By End-Use 17.14. India 17.14.1. Market Share Analysis, 2023 17.14.1.1. By Therapy 17.14.1.2. By Source 17.14.1.3. By Application 17.14.1.4. By End-Use 17.15. Bangladesh 17.15.1. Market Share Analysis, 2023 17.15.1.1. By Therapy 17.15.1.2. By Source 17.15.1.3. By Application 17.15.1.4. By End-Use 17.16. Australia 17.16.1. Market Share Analysis, 2023 17.16.1.1. By Therapy 17.16.1.2. By Source 17.16.1.3. By Application 17.16.1.4. By End-Use 17.17. New Zealand 17.17.1. Market Share Analysis, 2023 17.17.1.1. By Therapy 17.17.1.2. By Source 17.17.1.3. By Application 17.17.1.4. By End-Use 17.18. China 17.18.1. Market Share Analysis, 2023 17.18.1.1. By Therapy 17.18.1.2. By Source 17.18.1.3. By Application 17.18.1.4. By End-Use 17.19. Japan 17.19.1. Market Share Analysis, 2023 17.19.1.1. By Therapy 17.19.1.2. By Source 17.19.1.3. By Application 17.19.1.4. By End-Use 17.20. South Korea 17.20.1. Market Share Analysis, 2023 17.20.1.1. By Therapy 17.20.1.2. By Source 17.20.1.3. By Application 17.20.1.4. By End-Use 17.21. GCC Countries 17.21.1. Market Share Analysis, 2023 17.21.1.1. By Therapy 17.21.1.2. By Source 17.21.1.3. By Application 17.21.1.4. By End-Use 17.22. South Africa 17.22.1. Market Share Analysis, 2023 17.22.1.1. By Therapy 17.22.1.2. By Source 17.22.1.3. By Application 17.22.1.4. By End-Use 17.23. Israel 17.23.1. Market Share Analysis, 2023 17.23.1.1. By Therapy 17.23.1.2. By Source 17.23.1.3. By Application 17.23.1.4. By End-Use 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Therapy 18.3.3. By Source 18.3.4. By Application 18.3.5. By End-Use 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Lonza Group AG 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Novartis AG 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Bristol-Myers Squibb Company 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Corning Incorporated 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Holostem Terapie Avanzate S.r.l. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. CORESTEM, Inc 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Sanpower Group 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Tego Science 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Gilead Sciences 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Vericel Corporation 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports